Author: fabric-advanced-biology

Master MAP 3D / 2D

This year again, the 3d.FAB platform carried out an introductory week in 3D printing for students of the Master MAP 3D / 2D.

Exclusively, students were trained on silicon printing in a granular medium: a breakthrough innovation driven by our start up 3Deus Dynamics.

Thank you to the supervisor Eliane Espuche for her trust and to the students for their motivation.

New PhD !

Who is she? Meigge simoes

What is she doing? A doctorate on cancerology

Its goal: Modelling a 3D Tumor Microenvironment to overcome therapy resistance mechanisms on cancer patients

Its environment: the 3d.FAB platform and the Onco-pharmacology team (CRCLLeon berard center) led by Charles Dumontet

Dear Meig, welcome to the incredible thesis adventure!

cof_soft

Workshop – Additiv Médical

La plateforme 3d.FAB sera présente au côté de Poietis pour un workshop organisé par Additiv Médical sur la thématique « le bio-printing pour la création de tissus cutanés ».
Nous espérons vous y voir nombreux.

Plus d’infos ici : https://www.additiv.events/inscription

New PhD in 3d.FAB

The 3d.FAB team wishes you a very happy new year 2021.

Our 1st communication in 2021 marks the concretization of a strong partnership with Sartorius Stedim Biotech company through the launch of Laura Chastagnier‘s thesis “3D-UNIPROD”.

Her subject will focus on Bioprinting for biomolecules production and the development of tissues culture bioprocesses.

ISO 13485

The 3d.FAB platform is ISO 13485 certified by Bureau Veritas France.

Well done to our researchers who are contributing to the health innovations of today and tomorrow.

We are ready to print your medical devices.

#Medicaldevices #ISO #ISO13485 #Innovations #Health #3D #Print #Quality #Qualité #additivemanufacturing #bioprinting

(Université Claude Bernard Lyon 1, CNRS, UMR 5246)
credit photo : Lucas Lemarié

Evolution Project

Congratulations to Lucas Lemarié who begins his PhD work “Evolution” under the supervision of Jérôme Sohier (CNRS), Edwin-Joffrey Courtial (ICBMS) and Florence Russo (SEGULA Technologies).
“Evolution” project will focus on the production of organoids from induced pluripotent cells, with differentiations initiated by a process of bioprinting and 3D maturation.